$0.03
$-0.01 (-25.00%)
End-of-day quote: 05/31/2023
OTCPK:LCI
Lannett Company Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.93 | $17.84 | 0.00% | 9 | $19.17B |
| AUROPHARMA | Aurobindo Pharma | NSEI | Outperform | Rp1.19k | Rp1.29k | 0.00% | 20 | Rp714.20B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.30 | £28.11 | 0.00% | 9 | £4.42B |
| APN | Aspen Pharmacare Holdings | JSE | Outperform | R232.36 | R202.49 | 0.00% | 1 | R102.44B |
| RICHTER | BUSE | Outperform | Ft9.10k | Ft11.02k | 0.00% | 2 | Ft1.75T | |
| KRKG | Krka, d. d. | LJSE | Outperform | 130.00€ | 119.80€ | 0.00% | 0 | 3.88€B |
| PRGO | Perrigo Co PLC | NYSE | Outperform | $27.53 | $44.75 | 0.00% | 0 | $4.19B |
| GLENMARK | Glenmark Pharmaceuticals | NSEI | Outperform | Rp1.16k | Rp767.80 | 0.00% | 9 | Rp292.35B |
| AMRX | Amneal Pharmaceuticals | NYSE | Outperform | $6.68 | $6.13 | 0.00% | 1 | $2.09B |
| AMPH | Amphastar Pharmaceuticals | NasdaqGS | Outperform | $42.33 | $69.00 | 0.00% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $27.12 | $41.00 | 0.00% | 0 | $1.72B |
| AIP | Adcock Ingram Holdings | JSE | Hold | R56.78 | R55.97 | 0.00% | 1 | R8.11B |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $1.82 | $10.86 | 0.00% | 3 | $255.37M |
| ASRT | Assertio Holdings | NasdaqCM | Buy | $0.99 | $3.50 | 0.00% | 2 | $100.36M |
